ANI Pharmaceuticals (ANIP): If you compare the following articles yo...

Reply Private New

Replies (1) Next 10 Prev Next

Send PM Follow Ignore

Followers	0
Posts	54
Boards Moderated	0
Alias Born	03/13/2012

El Principe

Re: None

Friday, 12/27/2013 12:28:41 PM

Friday, December 27, 2013 12:28:41 PM

If you compare the following articles you will realize that we have the capability of manufacturing to a market of 1.6 Billion annually. That's more than double than what we had prior to this acquisition.

After merger
"We currently manufacture and market seven prescription products that we either developed internally or acquired. ANDAs for five additional generic products are pending at the FDA and we expect to submit six additional ANDAs in the remainder of 2013. These eleven generic products address a total annual market size of approximately $760 million, based on data from IMS Health."

http://finance.yahoo.com/news/biosante-pharmaceuticals-ani-pharmaceuticals-announce-120000900.html

Todays's news

All of these products have been previously approved by FDA as abbreviated new drug applications (ANDAs). The total current annual market for these products is $860 million per IMS Health.

http://www.news-medical.net/news/20131227/Teva-Pharmaceuticals-sells-31-generic-drug-products-to-ANI-Pharmaceuticals.aspx